£152.99

U.S. Drug Supply, Investigational Drugs and E-Prescriptions

Law

Price data last checked 149 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£153 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 582 days • 582 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 582 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £166 (308 days, 52.9%)

Price range: £153 - £166

Price levels: 5 different prices over 582 days

Description

Chapter 1 reports on the U.S. drug supply and the complex way it is interwoven with multiple stakeholders involved in each step of the process. When investigational drugs show promise for treating serious or life-threatening diseases, patients are often interested in obtaining access to them. Congress included a provision in the FDA Reauthorization Act of 2017 for GAO to review actions taken to facilitate access to these drugs. Chapter 2 describes (1) actions FDA and drug manufacturers have taken to broaden eligibility criteria for clinical trials, (2) actions FDA has taken to facilitate access to investigational drugs outside of clinical trials, and (3) information drug manufacturers have communicated to patients and physicians about access to investigational drugs outside of clinical trials. Chapter 3 reports on requiring e-prescriptions for coverage under part D of the Medicare program for prescription drugs that are controlled substances.

Product Specifications

Format: hardcover
ASIN: 1536174424
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 03 March 2020
Listed Since: 14 January 2020

Barcode

No barcode data available

U.S. Drug Supply, Investigational Drugs and E-Prescriptions

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Research Handbook on International Drug Policy

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Medicines, Medical Devices and the Law

World Pharmaceutical Industry

Social Aspects of Drug Discovery, Development and Commercialization

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Guide Pratique Des Médicaments Dorosz 2019

Medicines, Medical Devices and the Law

NATIONAL DRUG SHORTAGE: Trends & FDA Response (Public Health in the 21st Century; Health Care Issues, Costs and Access)

Prescription Drug Pricing: Cost & Control Concerns (Health Care Issues, Costs and Access)

Biosimilars and Interchangeable Biologics: Strategic Elements

Research and Development in the Pharmaceutical Industry

2013 U.S. Rx Company Planning Overview: Industry Trends To 2020

Dale and Appelbe's Pharmacy and Medicines Law Thirteenth Edition

Description and Analysis of the VA National Formulary

Drug Misuse and Community Pharmacy

Pharmaceutical Medicine (Oxford Specialist Handbooks)

Drug Information: A Guide for Pharmacists, Fourth Edition

Pharmaceutical Industry: Innovation & Developments (Business Issues, Competition and Entrepreneurship)

Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)

The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India

Global Issues in Pharmaceutical Marketing

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Dorosz guide pratique des medicaments 2023, 42e ed